Travere Therapeutics, Inc.TVTXNASDAQ

Loading chart...

Want to monitor TVTX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

No description available.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

Lloyds results signal deposit tensions - Barclays and Paragon tipped

Best Momentum Stocks to Buy for February 2nd

Atlassian to Report Q2 Earnings: What's in Store for the Stock?

3 Packaging Stocks to Watch Amid Industry Challenges

SoFi's Pullback Before The Breakout

Disney earnings top estimates, plus gold and silver volatility and price swings

RCL Best Booking Streak Ever: Signal of Strong Cruise Demand in 2026?

Visteon To Announce Fourth Quarter and Full Year 2025 Results on February 19

Disney Stock Sinks Despite Top-Line Beat

Charter Communications: Way Too Cheap At 6x P/E (Upgrade)

Xerox Holdings Stock Rises 7.4% Since Q4 Earnings Release

Novo Nordisk says CagriSema outperforms semaglutide in late-stage trial of type-2 diabetes patients

Current Chemicals Launches as Independent Specialty Materials Manufacturer, Building on 75-Year GE Legacy with Backing from Momentum Global Ventures

Tesla: A Musk Empire Is The Latest Upside Catalyst

Amkor Technology (AMKR) Reports Next Week: What Awaits?

PowerFleet (AIOT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Cleveland-Cliffs (CLF) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Earnings Preview: Becton Dickinson (BDX) Q1 Earnings Expected to Decline

Cincinnati Financial (CINF) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Silvercorp (SVM) Reports Next Week: Wall Street Expects Earnings Growth